Skip to Content

Antibodies, Volume 11, Issue 4

2022 December - 19 articles

Cover Story: Commercial monoclonal antibodies are growing and important components of modern therapies against a multitude of human diseases. Well-known high-resolution structural methods such as protein crystallography are often used to characterize antibody structures and to determine paratope and/or epitope binding regions in order to refine antibody design. However, many standard structural techniques require specialized sample preparation that may perturb antibody structure or require high concentrations or other conditions that are far from the conditions conducive to the accurate determination of antigen binding or kinetics. We describe here in this minireview the relatively new method of hydroxyl radical protein footprinting, a solution-state method that can provide structural and kinetic information on antibodies or antibody–antigen interactions useful for therapeutic antibody design. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (19)

  • Review
  • Open Access
29 Citations
8,720 Views
24 Pages

19 December 2022

Innumerable people worldwide die of cancer every year, although pharmaceutical therapy has actualized many benefits in human health. For background, anti-cancer drug development is difficult due to the multifactorial pathogenesis and complicated path...

  • Article
  • Open Access
2 Citations
2,947 Views
11 Pages

Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort

  • Raffaella Palazzo,
  • Katia Stefanantoni,
  • Marius Cadar,
  • Alessia Butera,
  • Valeria Riccieri,
  • Roberto Lande and
  • Loredana Frasca

15 December 2022

Systemic sclerosis (SSc) is a chronic disease characterized by skin/internal organ fibrosis, vasculopathy and autoimmunity. Chemokine (C-X-C motif) ligand 4 (CXCL4) is an early SSc biomarker that predicts worse disease outcome. We previously reported...

  • Article
  • Open Access
3 Citations
5,049 Views
10 Pages

SARS-CoV-2 Virus-like Particles (VLPs) Specifically Detect Humoral Immune Reactions in an ELISA-Based Platform

  • Stefan Hirschberg,
  • Hannes Bauer,
  • Julian Kamhieh-Milz,
  • Frauke Ringel,
  • Christoph Harms,
  • Omar Kamal Eddin,
  • Axel Pruß,
  • Katja Hanack and
  • Kai Schulze-Forster

12 December 2022

A key in controlling the SARS-CoV-2 pandemic is the assessment of the immune status of the population. We explored the utility of SARS-CoV-2 virus-like particles (VLPs) as antigens to detect specific humoral immune reactions in an enzyme-linked immun...

  • Article
  • Open Access
10 Citations
3,647 Views
11 Pages

Epitope Mapping of Anti-Mouse CCR3 Monoclonal Antibodies Using Flow Cytometry

  • Nami Tateyama,
  • Teizo Asano,
  • Hiroyuki Suzuki,
  • Guanjie Li,
  • Takeo Yoshikawa,
  • Tomohiro Tanaka,
  • Mika K. Kaneko and
  • Yukinari Kato

2 December 2022

The CC chemokine receptor 3 (CCR3) is a receptor for CC chemokines, including CCL5/RANTES, CCL7/MCP-3, and CCL11/eotaxin. CCR3 is expressed on the surface of eosinophils, basophils, a subset of Th2 lymphocytes, mast cells, and airway epithelial cells...

  • Article
  • Open Access
10 Citations
3,809 Views
14 Pages

A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG2a-f) Exerts Antitumor Activity in Xenograft Model

  • Teizo Asano,
  • Tomohiro Tanaka,
  • Hiroyuki Suzuki,
  • Guanjie Li,
  • Tomokazu Ohishi,
  • Manabu Kawada,
  • Takeo Yoshikawa,
  • Mika K. Kaneko and
  • Yukinari Kato

24 November 2022

The epithelial cell adhesion molecule (EpCAM) is a stem cell and carcinoma antigen, which mediates cellular adhesion and proliferative signaling by the proteolytic cleavage. In contrast to low expression in normal epithelium, EpCAM is frequently over...

  • Review
  • Open Access
36 Citations
12,038 Views
25 Pages

Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants

  • Alain Beck,
  • Christine Nowak,
  • Deborah Meshulam,
  • Kristina Reynolds,
  • David Chen,
  • Dennis B. Pacardo,
  • Samantha B. Nicholls,
  • Gregory J. Carven,
  • Zhenyu Gu and
  • Hongcheng Liu
  • + 4 authors

20 November 2022

Since the first approval of the anti-CD3 recombinant monoclonal antibody (mAb), muromonab-CD3, a mouse antibody for the prevention of transplant rejection, by the US Food and Drug Administration (FDA) in 1986, mAb therapeutics have become increasingl...

  • Case Report
  • Open Access
17 Citations
3,729 Views
8 Pages

Cross-Reactive Antibodies in Tick-Borne Encephalitis: Case Report and Literature Review

  • Tatjana Vilibic-Cavlek,
  • Thomas Ferenc,
  • Mateja Vujica Ferenc,
  • Maja Bogdanic,
  • Tanja Potocnik-Hunjadi,
  • Dario Sabadi,
  • Vladimir Savic,
  • Ljubo Barbic,
  • Vladimir Stevanovic and
  • Giovanni Savini
  • + 2 authors

20 November 2022

Flaviviruses are a heterogeneous group of viruses that may induce broad antigenic cross-reactivity. We present a patient who was admitted to the infectious disease department with symptoms suggestive of aseptic meningitis. During the clinical workup,...

  • Review
  • Open Access
12 Citations
4,509 Views
16 Pages

14 November 2022

Commercial monoclonal antibodies are growing and important components of modern therapies against a multitude of human diseases. Well-known high-resolution structural methods such as protein crystallography are often used to characterize antibody str...

  • Article
  • Open Access
7 Citations
3,094 Views
8 Pages

Neutralizing and Total/IgG Spike Antibody Responses Following Homologous CoronaVac vs. BNT162b2 Vaccination Up to 90 Days Post-Booster

  • Chin Shern Lau,
  • John Thundyil,
  • May Lin Helen Oh,
  • Soon Kieng Phua,
  • Ya Li Liang,
  • Yanfeng Li,
  • Jianxin Huo,
  • Yuhan Huang,
  • Biyan Zhang and
  • Tar Choon Aw
  • + 1 author

8 November 2022

Introduction: We documented the total spike antibody (S-Ab), IgG S-Ab and neutralizing antibody (N-Ab) responses of BNT162b2/CoronaVac vaccinees up to 90 days post-booster dose. Methods: We included 32 homologous regimen CoronaVac vaccinees and 136 B...

  • Article
  • Open Access
3 Citations
4,295 Views
13 Pages

Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chattogram Metropolitan Area, Bangladesh

  • Jahan Ara,
  • Md. Sirazul Islam,
  • Md. Tarek Ul Quader,
  • Anan Das,
  • F. M. Yasir Hasib,
  • Mohammad Saiful Islam,
  • Tazrina Rahman,
  • Seemanta Das,
  • M. A. Hassan Chowdhury and
  • Sharmin Chowdhury
  • + 1 author

7 November 2022

Seroprevalence studies of COVID-19 are used to assess the degree of undetected transmission in the community and different groups such as health care workers (HCWs) are deemed vulnerable due to their workplace hazards. The present study estimated the...

  • Article
  • Open Access
3 Citations
2,988 Views
39 Pages

25 October 2022

We investigated the short sequences involving Omicron 21K and Omicron 21L variants to reveal any possible molecular mimicry-associated autoimmunity risks and changes in those. We first identified common 6mers of the viral and human protein sequences...

  • Article
  • Open Access
18 Citations
6,675 Views
14 Pages

Rational Design and In Vivo Characterization of mRNA-Encoded Broadly Neutralizing Antibody Combinations against HIV-1

  • Elisabeth Narayanan,
  • Samantha Falcone,
  • Sayda M. Elbashir,
  • Husain Attarwala,
  • Kimberly Hassett,
  • Michael S. Seaman,
  • Andrea Carfi and
  • Sunny Himansu

24 October 2022

Monoclonal antibodies have been used successfully as recombinant protein therapy; however, for HIV, multiple broadly neutralizing antibodies may be necessary. We used the mRNA-LNP platform for in vivo co-expression of 3 broadly neutralizing antibodie...

  • Article
  • Open Access
3 Citations
3,455 Views
12 Pages

21 October 2022

In order to conduct a pediatric clinical trial, it is important to optimize pediatric dose as accurately as possible. In this study, a simple weight-based method known as ‘Salisbury Rule’ was used to predict pediatric dose for therapeutic...

  • Article
  • Open Access
9 Citations
5,992 Views
45 Pages

18 October 2022

The constant region of the immunoglobulin (IG) or antibody heavy gamma chain is frequently engineered to modify the effector properties of the therapeutic monoclonal antibodies. These variants are classified in regards to their effects on effector fu...

  • Article
  • Open Access
6 Citations
3,336 Views
10 Pages

Integrating Single Domain Antibodies into Field-Deployable Rapid Assays

  • George P. Anderson,
  • Lisa C. Shriver-Lake,
  • Jinny L. Liu and
  • Ellen R. Goldman

17 October 2022

Single domain antibodies (sdAb) are the recombinant variable heavy domains derived from camelid heavy-chain antibodies. While they have binding affinities equivalent to conventional antibodies, sdAb are only one-tenth the size and possess numerous ad...

  • Case Report
  • Open Access
2 Citations
4,244 Views
5 Pages

Alloimmune Neutropenia in a Neonate: Case Report and Review of Literature

  • Arun Prasath,
  • Alanna Grafius,
  • Mona Bonanno,
  • Steven Ambrusko and
  • Jayasree Nair

3 October 2022

Neonatal alloimmune neutropenia, variably referred to in the literature as NAIN, FNAIN or NIN, is a disorder of neutrophil destruction in newborns similar to better-known conditions such as hemolytic disease of the newborn and neonatal alloimmune thr...

  • Review
  • Open Access
29 Citations
11,564 Views
9 Pages

IgY Antibodies as Biotherapeutics in Biomedicine

  • Diana León-Núñez,
  • María Fernanda Vizcaíno-López,
  • Magdalena Escorcia,
  • Dolores Correa,
  • Elizabeth Pérez-Hernández and
  • Fernando Gómez-Chávez

29 September 2022

Since the discovery of antibodies by Emil Von Behring and Shibasaburo Kitasato during the 19th century, their potential for use as biotechnological reagents has been exploited in different fields, such as basic and applied research, diagnosis, and th...

  • Article
  • Open Access
8 Citations
9,382 Views
17 Pages

27 September 2022

Yeast surface display techniques have been increasingly employed as a tool for both the discovery and affinity maturation of antibodies. In this study, we describe the use of yeast surface display for the selection and affinity maturation of antibodi...

  • Article
  • Open Access
5 Citations
4,029 Views
15 Pages

High-Resolution Epitope Mapping and Affinity Binding Analysis Comparing a New Anti-Human LAG3 Rabbit Antibody Clone to the Commonly Used Mouse 17B4 Clone

  • P. Daniel Warren,
  • Mark S. Dodson,
  • Margaret H. Smith,
  • Terry H. Landowski,
  • John Douglas Palting and
  • Penny Towne

21 September 2022

Lymphocyte activation gene 3 (LAG3) is a T cell inhibitory receptor that promotes tumor cell immune escape and is a potential target for cancer diagnostic and immunotherapeutic applications. We used automated capillary electrophoresis (ACE), surface...

XFacebookLinkedIn
Antibodies - ISSN 2073-4468